US FDA concludes inspection of Biocon Biologics’ Insulins Facility in Malaysia

The scope of the inspection included one Drug Substance and one Drug Product manufacturing unit, a Medical Device Assembly unit, an Analytical Quality Control Laboratory, two Microbiological Control Laboratories, and two Warehouses.

Leave a Reply

Your email address will not be published. Required fields are marked *